Bottom line
What is TQVAX's expense ratio?
TQVAX's expense ratio is 0.99%, or about $99 a year on every $10,000 invested. That is more expensive than 66% of large value funds we track (median 0.81%). Its expense ratio includes a 0.25% 12b-1 marketing fee.
Updated Feb 25, 2026
TQVAX fee table
| Net expense ratio | 0.99% |
|---|---|
| Gross expense ratio | 2.31% |
| Management fee | 0.48% |
| 12b-1 (distribution) fee | 0.25% |
| Other expenses | 1.58% |
| Fee waiver / reimbursement | -1.32% |
Source: Fund prospectus fee table, filed Feb 25, 2026
What TQVAX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| TQVAX | $101 | $459 | $986 | $2,433 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 0.99% expense ratio costs roughly $54,900 in lost growth, versus about $45,600 for the median large value fund (0.81%).
Cheaper alternatives to TQVAX
These funds have a similar portfolio (by top-holdings overlap) and a lower expense ratio. Savings are per $10,000 invested.
*Difference in ending value of $10,000 after 20 years at a 6% gross annual return, net of each fund's expense ratio.